(Q36606751)

15 August 2017

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker (English)

1 reference

15 August 2017

M Pazianas

1

1 reference

15 August 2017

W A Blumentals

series ordinal

2

1 reference

15 August 2017

P D Miller

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Osteoporosis International

15 August 2017

1 reference

15 August 2017

19

1 reference

15 August 2017

6

1 reference

15 August 2017

773-779

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-007-0502-1

15 August 2017

0 references

cites work

Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2358932

New therapeutic agents for the treatment of bone diseases

30 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

New Insights Into the Molecular Mechanisms of Action of Bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Recent advances in understanding the mechanism of action of bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Ibandronate: a clinical pharmacological and pharmacokinetic update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Ten years' experience with alendronate for osteoporosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-007-0502-1

Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17999023

12 December 2020

inferred from PubMed ID database lookup

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17999023

12 December 2020

inferred from PubMed ID database lookup

Bisphosphonates and osteonecrosis of the jaw

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17999023

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00198-007-0502-1

1 reference

release_e557wgc4dvbqfdc25jjqybkvr4

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e557wgc4dvbqfdc25jjqybkvr4

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

17999023

1 reference